Literature DB >> 1730949

Effect of head elevation on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in head-injured patients.

Z Feldman1, M J Kanter, C S Robertson, C F Contant, C Hayes, M A Sheinberg, C A Villareal, R K Narayan, R G Grossman.   

Abstract

The traditional practice of elevating the head in order to lower intracranial pressure (ICP) in head-injured patients has been challenged in recent years. Some investigators argue that patients with intracranial hypertension should be placed in a horizontal position, the rationale being that this will increase the cerebral perfusion pressure (CPP) and thereby improve cerebral blood flow (CBF). However, ICP is generally significantly higher when the patient is in the horizontal position. This study was undertaken to clarify the issue of optimal head position in the care of head-injured patients. The effect of 0 degree and 30 degrees head elevation on ICP, CPP, CBF, mean carotid pressure, and other cerebral and systemic physiological parameters was studied in 22 head-injured patients. The mean carotid pressure was significantly lower when the patient's head was elevated at 30 degrees than at 0 degrees (84.3 +/- 14.5 mm Hg vs. 89.5 +/- 14.6 mm Hg), as was the mean ICP (14.1 +/- 6.7 mm Hg vs. 19.7 +/- 8.3 mm Hg). There was no statistically significant change in CPP, CBF, cerebral metabolic rate of oxygen, arteriovenous difference of lactate, or cerebrovascular resistance associated with the change in head position. The data indicate that head elevation to 30 degrees significantly reduced ICP in the majority of the 22 patients without reducing CPP or CBF.

Entities:  

Mesh:

Year:  1992        PMID: 1730949     DOI: 10.3171/jns.1992.76.2.0207

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  42 in total

1.  Mass Effect with Cerebral Infarction.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  The "Lund Concept" for the treatment of severe head trauma--physiological principles and clinical application.

Authors:  Per-Olof Grände
Journal:  Intensive Care Med       Date:  2006-08-02       Impact factor: 17.440

Review 3.  New concepts in treatment of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Anesthesiol Clin       Date:  2009-06

Review 4.  Management of intracranial hypertension.

Authors:  Leonardo Rangel-Castilla; Leonardo Rangel-Castillo; Shankar Gopinath; Claudia S Robertson
Journal:  Neurol Clin       Date:  2008-05       Impact factor: 3.806

5.  Continuous optical monitoring of cerebral hemodynamics during head-of-bed manipulation in brain-injured adults.

Authors:  Meeri N Kim; Brian L Edlow; Turgut Durduran; Suzanne Frangos; Rickson C Mesquita; Joshua M Levine; Joel H Greenberg; Arjun G Yodh; John A Detre
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

6.  Secondary insults during intrahospital transport of neurosurgical intensive care patients.

Authors:  A Bekar; Z Ipekoglu; K Türeyen; H Bilgin; G Korfali; E Korfali
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 7.  Acute Management of Traumatic Brain Injury.

Authors:  Michael A Vella; Marie L Crandall; Mayur B Patel
Journal:  Surg Clin North Am       Date:  2017-10       Impact factor: 2.741

8.  Detection and characterization of tree shrew retinal venous pulsations: An animal model to study human retinal venous pulsations.

Authors:  Michael Dattilo; A Thomas Read; Brian C Samuels; C Ross Ethier
Journal:  Exp Eye Res       Date:  2019-06-06       Impact factor: 3.467

Review 9.  Head Injury- A Maxillofacial Surgeon's Perspective.

Authors:  Muralee Mohan Choonthar; Ananthan Raghothaman; Rajendra Prasad; S Pradeep; Kalpa Pandya
Journal:  J Clin Diagn Res       Date:  2016-01-01

10.  Emergency Neurological Life Support: Intracranial Hypertension and Herniation.

Authors:  Rhonda Cadena; Michael Shoykhet; Jonathan J Ratcliff
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.